Announcement on Receipt of Notice of Arbitration
Filed with SSE · · 3 pages · Chinese
Shanghai Allist Pharmaceuticals Co. Ltd. on 6ix
Earlier from Shanghai Allist Pharmaceuticals
- Announcement on Resignation of Non-independent Director
- Announcement on Implementation of Dividend Distribution for 2023
- Announcement on Resolutions of 2023 Annual General Meeting
- Special Report on Storage and Actual Use of Raised Funds in 2023
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of AST2169 Liposome for Injection
Later from Shanghai Allist Pharmaceuticals
- Announcement on the Plan to Reduce Shares Held by the Company's Shareholders
- Semi-annual Report 2024
- Announcement on the Implementation of Semi-annual Dividend Distribution in 2024
- Announcement on Signing Drug Technology License and Development Agreement with Jacobio
- Announcement on Attending Semi-annual Collective Performance Briefing 2024 for Pharmaceutical and Biological Products Companies on STAR Market
Follow Shanghai Allist Pharmaceuticals into a list and get an email when it puts out news.
Follow Shanghai Allist Pharmaceuticals